Mobidiag and Unilabs enter into agreement over use of Amplidiag product line for molecular gastrointestinal diagnostics

03-Sep-2015 - Finland

Mobidiag Ltd and Unilabs announced an agreement covering the supply of Amplidiag products over the next four years for Unilabs in Sweden and Norway.

The Amplidiag product line covers six diagnostic products for various gastrointestinal infections, including tests for gastroenteritis, carbapenem- and vancomycin-resistance screening, as well as non-invasive Helicobacter pylori testing. The product line brings a improvement to clinical laboratory processes, patient management and infection control measures by providing sensitive, comprehensive and rapid diagnostic results.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances